SlideShare a Scribd company logo
1 of 24
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  1
CMI/Compas Study on Doctors’ Views of
Direct-to-Consumer Drug Advertising
In Preparation for the
FDA Survey of Clinicians on
Direct-to-Consumer Drug Advertising
Conducted on April 25, 2013
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  2
In 2002, the FDA conducted a study of HCPs to
understand their attitudes and behaviors
associated with DTC advertising of prescription
drugs…
The 2002 physician questionnaire asked for information regarding the
frequency of questions physicians received from patients, physicians’
responses to questions regarding patient questions, and prescribing
behaviors involved in a recent, specific encounter in which a DTC-
advertised drug was discussed. Finally, general questions were asked
about physicians’ opinions regarding DTC advertising.
The results of that study can be found on
http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas
/DrugMarketingAdvertisingandCommunicationsResearch/UCM152890.
pdf
This week the FDA announced their plan to conduct a new survey
focusing on physicians and other healthcare professionals to understand
the effect that direct-to-consumer (DTC) pharmaceutical advertising has
on their prescribers’ behaviors; as well as gain their perspective on
whether or not DTC drug marketing results in inappropriate requests for
prescriptions or an overestimation by patients of their efficacy.
As this announcement generated much curiosity with our media teams
and our many clients, CMI/Compas decided to field our own ByDoctor®
PulseTM study focusing on physicians perceptions of DTC – surveying
both primary care and specialty physicians. Perhaps the responses here
can serve as leading indicators for what’s to come…
Survey Responders: 104
50% from Primary Care
50% from Specialty
48% agree that DTC
informs, educates and
empowers patients
68% agree that DTC
encourages patients
to contact a clinician
52% of agree that DTC
removes stigma
associated with
certain diseases
Only 20% of physicians
agree that DTC advertising
strengthens a patient’s
relationship with a clinician.
81% of physicians agree DTC
advertising encourages drug
over-utilization
78% of physicians agree DTC
advertising ultimately
increases the cost of
healthcare
Over 89% have received a
specific medication request
from a patient as a result of
an advertisement they saw.
43% changed their
prescribing as a result.
Summary of Key Findings
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  3
On April 25, 2013, Compas conducted a ByDoctor®
PULSE™ study of physicians to gauge HCP perceptions.
HERE IS WHAT WE UNCOVERED…IN DETAIL!
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  4
Nearly 53% of doctors believe Direct-to-Consumer
pharmaceutical advertising should be scaled back
52.90%
18.30%
2.90%
26.00%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Should be scaled back Should be eliminated Should be increased Should continue as is
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  5
Over 89% have received a specific medication request from a
patient as a result of an advertisement they saw. 43% changed
their prescribing as a result.
10.60%
46.20%
43.30%
Never received requests
Received requests, but did not change
prescribing
Received requests and changed
prescribing
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  6
78% feel that Direct-to-Consumer advertising leads to a
preference for brand name drugs when a generic is adequate
78.80%
21.20%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
1
Yes
No
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  7
48% of physicians agree (5% strongly; 43% somewhat) that
Direct-to-Consumer pharmaceutical advertising informs,
educates and empowers patients.
4.80%
43.30%
7.70%
32.70%
11.50%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  8
68% of physicians agree (18% strongly; 50% somewhat) that
Direct-to-Consumer pharmaceutical advertising encourages
patients to contact a clinician
18.30%
50.00%
12.50%
14.40%
4.80%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat
Disagree
Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  9
64% of physicians agree (13% strongly; 51% somewhat) that
Direct-to-Consumer pharmaceutical advertising promotes
patient dialogue with health care provider(s)
12.50%
51.00%
16.30%
14.40%
5.80%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  10
Only 20% of physicians agree (5% strongly; 15% somewhat)
that Direct-to-Consumer pharmaceutical advertising
strengthens a patient's relationship with a clinician
4.80%
15.40%
24.00%
39.40%
16.30%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  11
52% of physicians agree (9% strongly; 43% somewhat) that
Direct-to-Consumer pharmaceutical advertising removes
stigma associated with certain diseases
8.60%
42.90%
21.90% 21.00%
5.70%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat
Disagree
Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  12
53% of physicians disagree (19% strongly; 34% somewhat)
Direct-to-Consumer pharmaceutical advertising reduces
underdiagnoses and under-treatment of conditions
4.60%
22.20%
20.40%
34.30%
18.50%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat
Disagree
Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  13
63% of physicians agree (15% strongly; 48% somewhat) that
Direct-to-Consumer pharmaceutical advertising misinforms
patients
15.00%
47.70%
17.80%
15.00%
4.70%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  14
74% of physicians agree (28% strongly; 46% somewhat) that
Direct-to-Consumer pharmaceutical advertising
overemphasizes drug benefits
27.60%
45.70%
17.10%
7.60%
1.90%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat
Disagree
Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  15
50% of physicians disagree (18% strongly; 32% somewhat) that
Direct-to-Consumer pharmaceutical advertising encourages
patient compliance
6.70%
18.30%
25.00%
31.70%
18.30%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat
Disagree
Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  16
52% of physicians disagree (21% strongly; 31% somewhat)
Direct-to-Consumer pharmaceutical advertising encourages
product competition and lower prices
5.70%
22.90%
20.00%
30.50%
21.00%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat
Disagree
Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  17
68% of physicians agree (14% strongly; 54% somewhat) that
Direct-to-Consumer pharmaceutical advertising promotes new
drugs before safety profiles are fully known
13.90%
53.70%
11.10%
15.70%
5.60%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  18
81% of physicians agree (25% strongly; 56% somewhat) Direct-
to-Consumer pharmaceutical advertising encourages drug
overutilization
24.80%
56.20%
11.40%
5.70%
1.90%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  19
65% of physicians agree (20% strongly; 45% somewhat) that
Direct-to-Consumer pharmaceutical advertising leads to
inappropriate prescribing
20.00%
44.80%
21.90%
10.50%
2.90%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  20
51% of physicians agree (15% strongly; 36% somewhat) that
Direct-to-Consumer pharmaceutical advertising wastes
appointment time
15.00%
35.50%
22.40%
23.40%
3.70%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat Disagree Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  21
65% of physicians agree (23% strongly; 42% somewhat) that
Direct-to-Consumer pharmaceutical advertising is
not rigorously regulated
23.10%
41.70%
16.70%
13.90%
4.60%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
Strongly Agree Somewhat Agree Don't Have an
Opinion
Somewhat
Disagree
Strongly Disagree
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  22
78% of physicians agree that Direct-to-Consumer
pharmaceutical advertising ultimately increases cost of
healthcare
77.90%
5.80%
12.50%
3.80%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
Ultimately increases the
cost of healthcare
Ultimately reduces the
cost of healthcare
Does not change the cost
of healthcare
No opinion
ByDoctor® PULSETM
is a rapid response marketing research survey that provides instant audience
insights around key campaign questions.
• Research all healthcare professionals by specialty, geography, value segment and country.
• Match your target list to over 1.7 million HCPs, spanning more than 27 specialties.
• 100% customized surveys include up to 7 questions.
• Receive responses within hours.
Valuable, real-time insights and data with ByDoctor® PULSETM
• Gauge brand awareness and track campaign effectiveness.
• Anticipate prescribing patterns after change in product label, formulary access, price increase or
indications.
• Assess reaction to clinical trial data or promotional efforts by a competitor.
• Evaluate satisfaction and message retention for educational programs or conferences.
Highlights
• Successfully engage with HCPs through their preferred media channels
• Effectively measure target audience reactions as the market changes,
including decisions made by governing bodies and current events
affecting your brand
• Launch key questions and receive responses rapidly, within hours
• Integrate research findings with CMI/Compas’ experience and strategic
customer insights across multi-channel, non-personal promotion
campaigns
© 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  24
To Find Out How Your Target Physicians Feel Towards
DTC Advertising
Please contact:
oYour CMI Media Director or Compas Lead
oOr Lindsay Dinan: ldinan@cmicompas.com

More Related Content

What's hot

Direct to Consumer Advertising Presentation
Direct to Consumer Advertising PresentationDirect to Consumer Advertising Presentation
Direct to Consumer Advertising Presentationcstam
 
Lessons Learned from the Ethical Challenges of Marketing in Healthcare
Lessons Learned from the Ethical Challenges of Marketing in HealthcareLessons Learned from the Ethical Challenges of Marketing in Healthcare
Lessons Learned from the Ethical Challenges of Marketing in HealthcareSandeepkumar Balabbigari, PharmD, RPh
 
Use of testimonials and endorsements in prescription drug advertisements
Use of testimonials and endorsements in prescription drug advertisementsUse of testimonials and endorsements in prescription drug advertisements
Use of testimonials and endorsements in prescription drug advertisementsFreedom Monk
 
The science of hope
The science of hopeThe science of hope
The science of hopeFreedom Monk
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalJorgeventura2014
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalGeorgi Daskalov
 
Ethical & unethical pharma market
Ethical & unethical pharma marketEthical & unethical pharma market
Ethical & unethical pharma marketFaheem Siddiqui
 
Dr. DelConte\'s Presentation
Dr. DelConte\'s PresentationDr. DelConte\'s Presentation
Dr. DelConte\'s Presentationmjfanelli
 
13. 2015 mwan 010815 testimony to federal election commission 1 8-15
13.  2015 mwan 010815  testimony to federal election commission  1 8-1513.  2015 mwan 010815  testimony to federal election commission  1 8-15
13. 2015 mwan 010815 testimony to federal election commission 1 8-15MedicalWhistleblower
 
‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical market‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical marketNitin Patel
 
Safe Prescribing Practices Conference for Medical Professionals, June 2013
Safe Prescribing Practices Conference for Medical Professionals, June 2013Safe Prescribing Practices Conference for Medical Professionals, June 2013
Safe Prescribing Practices Conference for Medical Professionals, June 2013Heidi Denton
 
Top Trends in Orphan Drugs
Top Trends in Orphan DrugsTop Trends in Orphan Drugs
Top Trends in Orphan DrugsBill Smith
 

What's hot (16)

Direct to Consumer Advertising Presentation
Direct to Consumer Advertising PresentationDirect to Consumer Advertising Presentation
Direct to Consumer Advertising Presentation
 
Dtc presentation final apr.30 pdf
Dtc presentation final apr.30 pdfDtc presentation final apr.30 pdf
Dtc presentation final apr.30 pdf
 
Lessons Learned from the Ethical Challenges of Marketing in Healthcare
Lessons Learned from the Ethical Challenges of Marketing in HealthcareLessons Learned from the Ethical Challenges of Marketing in Healthcare
Lessons Learned from the Ethical Challenges of Marketing in Healthcare
 
7 Drivers: Pharmaceutical Television Advertising - John G. Baresky
7 Drivers: Pharmaceutical Television Advertising - John G. Baresky7 Drivers: Pharmaceutical Television Advertising - John G. Baresky
7 Drivers: Pharmaceutical Television Advertising - John G. Baresky
 
Use of testimonials and endorsements in prescription drug advertisements
Use of testimonials and endorsements in prescription drug advertisementsUse of testimonials and endorsements in prescription drug advertisements
Use of testimonials and endorsements in prescription drug advertisements
 
The science of hope
The science of hopeThe science of hope
The science of hope
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Ethical & unethical pharma market
Ethical & unethical pharma marketEthical & unethical pharma market
Ethical & unethical pharma market
 
Dr. DelConte\'s Presentation
Dr. DelConte\'s PresentationDr. DelConte\'s Presentation
Dr. DelConte\'s Presentation
 
13. 2015 mwan 010815 testimony to federal election commission 1 8-15
13.  2015 mwan 010815  testimony to federal election commission  1 8-1513.  2015 mwan 010815  testimony to federal election commission  1 8-15
13. 2015 mwan 010815 testimony to federal election commission 1 8-15
 
BRP Pharmaceuticals
BRP PharmaceuticalsBRP Pharmaceuticals
BRP Pharmaceuticals
 
‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical market‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical market
 
Safe Prescribing Practices Conference for Medical Professionals, June 2013
Safe Prescribing Practices Conference for Medical Professionals, June 2013Safe Prescribing Practices Conference for Medical Professionals, June 2013
Safe Prescribing Practices Conference for Medical Professionals, June 2013
 
Top Trends in Orphan Drugs
Top Trends in Orphan DrugsTop Trends in Orphan Drugs
Top Trends in Orphan Drugs
 
IFPMA Code of Practice 2012
IFPMA Code of Practice2012IFPMA Code of Practice2012
IFPMA Code of Practice 2012
 

Viewers also liked

MARS Study Outlines Online Habits of Health Consumers
MARS Study Outlines Online Habits of Health Consumers MARS Study Outlines Online Habits of Health Consumers
MARS Study Outlines Online Habits of Health Consumers Path of the Blue Eye Project
 
DNA Testing: Living Longer Via Personal Genomics
DNA Testing: Living Longer Via Personal GenomicsDNA Testing: Living Longer Via Personal Genomics
DNA Testing: Living Longer Via Personal GenomicsMelanie Swan
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 projectmdragoescu
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가? Hyung Jin Choi
 
DNA Roulette: Understanding genetics and genetic testing through gaming
DNA Roulette: Understanding genetics and genetic testing through gamingDNA Roulette: Understanding genetics and genetic testing through gaming
DNA Roulette: Understanding genetics and genetic testing through gamingcarrie.heeter
 
Direct to Consumer Genetic Testing
Direct to Consumer Genetic TestingDirect to Consumer Genetic Testing
Direct to Consumer Genetic TestingNathan J. Kerr
 
Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1cwoodland
 
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24Hyung Jin Choi
 
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010The Spittoon
 
Regulatory oversight of genetic testing in Canada: Health Canada perspective
Regulatory oversight of genetic testing in Canada: Health Canada perspectiveRegulatory oversight of genetic testing in Canada: Health Canada perspective
Regulatory oversight of genetic testing in Canada: Health Canada perspectiveMaRS Discovery District
 
의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래Hyung Jin Choi
 
Direct To Consumer Genomics and the Future of Healthcare
Direct To Consumer Genomics and the Future of HealthcareDirect To Consumer Genomics and the Future of Healthcare
Direct To Consumer Genomics and the Future of HealthcareRyan Squire
 
Medical Utopias: The Promise of Emerging Technologies
Medical Utopias: The Promise of Emerging TechnologiesMedical Utopias: The Promise of Emerging Technologies
Medical Utopias: The Promise of Emerging TechnologiesAlex Tang
 
Why DTC Advertising Shouldn't Make Us Feel Guilty
Why DTC Advertising Shouldn't Make Us Feel GuiltyWhy DTC Advertising Shouldn't Make Us Feel Guilty
Why DTC Advertising Shouldn't Make Us Feel GuiltyGrey Matter Marketing
 
Brand advertising
Brand advertisingBrand advertising
Brand advertisingdeewakar
 
Project report marketing- abott
Project report  marketing- abottProject report  marketing- abott
Project report marketing- abottStudsPlanet.com
 

Viewers also liked (17)

MARS Study Outlines Online Habits of Health Consumers
MARS Study Outlines Online Habits of Health Consumers MARS Study Outlines Online Habits of Health Consumers
MARS Study Outlines Online Habits of Health Consumers
 
DNA Testing: Living Longer Via Personal Genomics
DNA Testing: Living Longer Via Personal GenomicsDNA Testing: Living Longer Via Personal Genomics
DNA Testing: Living Longer Via Personal Genomics
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?
 
DNA Roulette: Understanding genetics and genetic testing through gaming
DNA Roulette: Understanding genetics and genetic testing through gamingDNA Roulette: Understanding genetics and genetic testing through gaming
DNA Roulette: Understanding genetics and genetic testing through gaming
 
Direct to Consumer Genetic Testing
Direct to Consumer Genetic TestingDirect to Consumer Genetic Testing
Direct to Consumer Genetic Testing
 
Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1
 
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
 
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
 
Regulatory oversight of genetic testing in Canada: Health Canada perspective
Regulatory oversight of genetic testing in Canada: Health Canada perspectiveRegulatory oversight of genetic testing in Canada: Health Canada perspective
Regulatory oversight of genetic testing in Canada: Health Canada perspective
 
의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래의료 빅데이터와 인공지능의 현재와 미래
의료 빅데이터와 인공지능의 현재와 미래
 
Direct To Consumer Genomics and the Future of Healthcare
Direct To Consumer Genomics and the Future of HealthcareDirect To Consumer Genomics and the Future of Healthcare
Direct To Consumer Genomics and the Future of Healthcare
 
Medical Utopias: The Promise of Emerging Technologies
Medical Utopias: The Promise of Emerging TechnologiesMedical Utopias: The Promise of Emerging Technologies
Medical Utopias: The Promise of Emerging Technologies
 
Biology Futures
Biology FuturesBiology Futures
Biology Futures
 
Why DTC Advertising Shouldn't Make Us Feel Guilty
Why DTC Advertising Shouldn't Make Us Feel GuiltyWhy DTC Advertising Shouldn't Make Us Feel Guilty
Why DTC Advertising Shouldn't Make Us Feel Guilty
 
Brand advertising
Brand advertisingBrand advertising
Brand advertising
 
Project report marketing- abott
Project report  marketing- abottProject report  marketing- abott
Project report marketing- abott
 

Similar to Doctors’ Views of Direct-to-Consumer Drug Advertising

Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowDebra Harris
 
Prescription Medicines Costs in Context May 2020
Prescription Medicines Costs in Context May 2020Prescription Medicines Costs in Context May 2020
Prescription Medicines Costs in Context May 2020PhRMA
 
Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021PhRMA
 
Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021PhRMA
 
Market access conference NAPM
Market access conference NAPMMarket access conference NAPM
Market access conference NAPMnapmSA
 
Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Synygy
 
The Patient Perspective: Trusting Pharma
The Patient Perspective: Trusting PharmaThe Patient Perspective: Trusting Pharma
The Patient Perspective: Trusting Pharmaaccenture
 
Prescription Medicines Costs in Context October 2020
Prescription Medicines Costs in Context October 2020Prescription Medicines Costs in Context October 2020
Prescription Medicines Costs in Context October 2020PhRMA
 
MHC 750 JH 01 Direct To Consumer Drug Advertising
MHC 750 JH 01 Direct To Consumer Drug AdvertisingMHC 750 JH 01 Direct To Consumer Drug Advertising
MHC 750 JH 01 Direct To Consumer Drug AdvertisingLeslie Pirtle, MM, MEd
 
D T C Advertising
D T C AdvertisingD T C Advertising
D T C Advertisingguest78c907
 
Creating the digital patient home
Creating the digital patient homeCreating the digital patient home
Creating the digital patient homeGeorge Van Antwerp
 
Prescription Medicines Costs in Context April 2022
Prescription Medicines Costs in Context April 2022Prescription Medicines Costs in Context April 2022
Prescription Medicines Costs in Context April 2022PhRMA
 
Prescription Medicines Costs in Context March 2022
Prescription Medicines Costs in Context March 2022Prescription Medicines Costs in Context March 2022
Prescription Medicines Costs in Context March 2022PhRMA
 
Pathways to Patient Engagement: Insights from the Physician Community
Pathways to Patient Engagement: Insights from the Physician CommunityPathways to Patient Engagement: Insights from the Physician Community
Pathways to Patient Engagement: Insights from the Physician CommunityKathleen Poulos
 
Marketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareMarketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareOgilvy Consulting
 
Dtcpresentationfinal 12941850285073-phpapp01 (1)
Dtcpresentationfinal 12941850285073-phpapp01 (1)Dtcpresentationfinal 12941850285073-phpapp01 (1)
Dtcpresentationfinal 12941850285073-phpapp01 (1)Chris Nichols
 
Big pharma and modern medicine
Big pharma and modern medicineBig pharma and modern medicine
Big pharma and modern medicinesohrab642
 
2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience 2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience GSW
 

Similar to Doctors’ Views of Direct-to-Consumer Drug Advertising (20)

Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
 
Prescription Medicines Costs in Context May 2020
Prescription Medicines Costs in Context May 2020Prescription Medicines Costs in Context May 2020
Prescription Medicines Costs in Context May 2020
 
Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021
 
Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021
 
Market access conference NAPM
Market access conference NAPMMarket access conference NAPM
Market access conference NAPM
 
Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Pharma Industry Trends in 2015
Pharma Industry Trends in 2015
 
The Patient Perspective: Trusting Pharma
The Patient Perspective: Trusting PharmaThe Patient Perspective: Trusting Pharma
The Patient Perspective: Trusting Pharma
 
Prescription Medicines Costs in Context October 2020
Prescription Medicines Costs in Context October 2020Prescription Medicines Costs in Context October 2020
Prescription Medicines Costs in Context October 2020
 
MHC 750 JH 01 Direct To Consumer Drug Advertising
MHC 750 JH 01 Direct To Consumer Drug AdvertisingMHC 750 JH 01 Direct To Consumer Drug Advertising
MHC 750 JH 01 Direct To Consumer Drug Advertising
 
D T C Advertising
D T C AdvertisingD T C Advertising
D T C Advertising
 
Creating the digital patient home
Creating the digital patient homeCreating the digital patient home
Creating the digital patient home
 
Prescription Medicines Costs in Context April 2022
Prescription Medicines Costs in Context April 2022Prescription Medicines Costs in Context April 2022
Prescription Medicines Costs in Context April 2022
 
Prescription Medicines Costs in Context March 2022
Prescription Medicines Costs in Context March 2022Prescription Medicines Costs in Context March 2022
Prescription Medicines Costs in Context March 2022
 
Pathways to Patient Engagement: Insights from the Physician Community
Pathways to Patient Engagement: Insights from the Physician CommunityPathways to Patient Engagement: Insights from the Physician Community
Pathways to Patient Engagement: Insights from the Physician Community
 
Marketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareMarketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric Healthcare
 
Dtcpresentationfinal 12941850285073-phpapp01 (1)
Dtcpresentationfinal 12941850285073-phpapp01 (1)Dtcpresentationfinal 12941850285073-phpapp01 (1)
Dtcpresentationfinal 12941850285073-phpapp01 (1)
 
Big pharma and modern medicine
Big pharma and modern medicineBig pharma and modern medicine
Big pharma and modern medicine
 
Pharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and IntelligencePharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and Intelligence
 
2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience 2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience
 
MD Insights for Patient Engagement
MD Insights for Patient EngagementMD Insights for Patient Engagement
MD Insights for Patient Engagement
 

More from CMI_Compas

The Beginner's Guide to Googlebot Optimization
The Beginner's Guide to Googlebot OptimizationThe Beginner's Guide to Googlebot Optimization
The Beginner's Guide to Googlebot OptimizationCMI_Compas
 
New Native Advertising Guidelines and What Steps You Need to Take
New Native Advertising Guidelines and What Steps You Need to TakeNew Native Advertising Guidelines and What Steps You Need to Take
New Native Advertising Guidelines and What Steps You Need to TakeCMI_Compas
 
Ad Blocking Goes Mobile with iOS9- Implications for Pharma and Readiness
Ad Blocking Goes Mobile with iOS9- Implications for Pharma and ReadinessAd Blocking Goes Mobile with iOS9- Implications for Pharma and Readiness
Ad Blocking Goes Mobile with iOS9- Implications for Pharma and ReadinessCMI_Compas
 
Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...
Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...
Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...CMI_Compas
 
CMI/Compas Endocrine Today Focus on Diabetes
CMI/Compas Endocrine Today Focus on Diabetes CMI/Compas Endocrine Today Focus on Diabetes
CMI/Compas Endocrine Today Focus on Diabetes CMI_Compas
 
Pharma Hotlist- Wearables
Pharma Hotlist- Wearables Pharma Hotlist- Wearables
Pharma Hotlist- Wearables CMI_Compas
 
Connecting the Dots of Point of Care Engagement Opportunities Infographic
Connecting the Dots of Point of Care Engagement Opportunities InfographicConnecting the Dots of Point of Care Engagement Opportunities Infographic
Connecting the Dots of Point of Care Engagement Opportunities InfographicCMI_Compas
 
Digital Perspectives Research Findings of Healthcare Professionals
Digital Perspectives Research Findings of Healthcare ProfessionalsDigital Perspectives Research Findings of Healthcare Professionals
Digital Perspectives Research Findings of Healthcare ProfessionalsCMI_Compas
 

More from CMI_Compas (8)

The Beginner's Guide to Googlebot Optimization
The Beginner's Guide to Googlebot OptimizationThe Beginner's Guide to Googlebot Optimization
The Beginner's Guide to Googlebot Optimization
 
New Native Advertising Guidelines and What Steps You Need to Take
New Native Advertising Guidelines and What Steps You Need to TakeNew Native Advertising Guidelines and What Steps You Need to Take
New Native Advertising Guidelines and What Steps You Need to Take
 
Ad Blocking Goes Mobile with iOS9- Implications for Pharma and Readiness
Ad Blocking Goes Mobile with iOS9- Implications for Pharma and ReadinessAd Blocking Goes Mobile with iOS9- Implications for Pharma and Readiness
Ad Blocking Goes Mobile with iOS9- Implications for Pharma and Readiness
 
Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...
Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...
Potential of One Click Rule to Change Pharma Marketing: How a Bill in Congres...
 
CMI/Compas Endocrine Today Focus on Diabetes
CMI/Compas Endocrine Today Focus on Diabetes CMI/Compas Endocrine Today Focus on Diabetes
CMI/Compas Endocrine Today Focus on Diabetes
 
Pharma Hotlist- Wearables
Pharma Hotlist- Wearables Pharma Hotlist- Wearables
Pharma Hotlist- Wearables
 
Connecting the Dots of Point of Care Engagement Opportunities Infographic
Connecting the Dots of Point of Care Engagement Opportunities InfographicConnecting the Dots of Point of Care Engagement Opportunities Infographic
Connecting the Dots of Point of Care Engagement Opportunities Infographic
 
Digital Perspectives Research Findings of Healthcare Professionals
Digital Perspectives Research Findings of Healthcare ProfessionalsDigital Perspectives Research Findings of Healthcare Professionals
Digital Perspectives Research Findings of Healthcare Professionals
 

Recently uploaded

Master the Art of Digital Recruitment in Asia.pdf
Master the Art of Digital Recruitment in Asia.pdfMaster the Art of Digital Recruitment in Asia.pdf
Master the Art of Digital Recruitment in Asia.pdfHigher Education Marketing
 
Best digital marketing e-book form bignners
Best digital marketing e-book form bignnersBest digital marketing e-book form bignners
Best digital marketing e-book form bignnersmuntasibkhan58
 
social media optimization complete indroduction
social media optimization complete indroductionsocial media optimization complete indroduction
social media optimization complete indroductioninfoshraddha747
 
A Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | BanyanbrainA Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | BanyanbrainBanyanbrain
 
Fiverr's Product Marketing Interview Assignment
Fiverr's Product Marketing Interview AssignmentFiverr's Product Marketing Interview Assignment
Fiverr's Product Marketing Interview AssignmentFarrel Brest
 
Digital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G AgeDigital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G AgeDigiKarishma
 
5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software Solutions5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software SolutionsDevherds Software Solutions
 
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...CIO Business World
 
What’s the difference between Affiliate Marketing and Brand Partnerships?
What’s the difference between Affiliate Marketing and Brand Partnerships?What’s the difference between Affiliate Marketing and Brand Partnerships?
What’s the difference between Affiliate Marketing and Brand Partnerships?Partnercademy
 
The Evolution of Internet : How consumers use technology and its impact on th...
The Evolution of Internet : How consumers use technology and its impact on th...The Evolution of Internet : How consumers use technology and its impact on th...
The Evolution of Internet : How consumers use technology and its impact on th...sowmyrao14
 
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdfResearch and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdfVWO
 
Codes and Conventions of Film Magazine Websites.pptx
Codes and Conventions of Film Magazine Websites.pptxCodes and Conventions of Film Magazine Websites.pptx
Codes and Conventions of Film Magazine Websites.pptxGeorgeCulica
 
Miss Immigrant USA Activity Pageant Program.pdf
Miss Immigrant USA Activity Pageant Program.pdfMiss Immigrant USA Activity Pageant Program.pdf
Miss Immigrant USA Activity Pageant Program.pdfMagdalena Kulisz
 
Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...
Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...
Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...CIO Business World
 
Professional Sales Representative by Sahil Srivastava.pptx
Professional Sales Representative by Sahil Srivastava.pptxProfessional Sales Representative by Sahil Srivastava.pptx
Professional Sales Representative by Sahil Srivastava.pptxSahil Srivastava
 
Fueling A_B experiments with behavioral insights (1).pdf
Fueling A_B experiments with behavioral insights (1).pdfFueling A_B experiments with behavioral insights (1).pdf
Fueling A_B experiments with behavioral insights (1).pdfVWO
 
Prezentare Brandfluence 2023 - Social Media Trends
Prezentare Brandfluence 2023 - Social Media TrendsPrezentare Brandfluence 2023 - Social Media Trends
Prezentare Brandfluence 2023 - Social Media TrendsCristian Manafu
 
Codes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptxCodes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptxGeorgeCulica
 
14principles of management by hanry fayol.pptx
14principles of management by hanry fayol.pptx14principles of management by hanry fayol.pptx
14principles of management by hanry fayol.pptxswarajkoli3
 
Most Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdf
Most Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdfMost Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdf
Most Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdfCIO Business World
 

Recently uploaded (20)

Master the Art of Digital Recruitment in Asia.pdf
Master the Art of Digital Recruitment in Asia.pdfMaster the Art of Digital Recruitment in Asia.pdf
Master the Art of Digital Recruitment in Asia.pdf
 
Best digital marketing e-book form bignners
Best digital marketing e-book form bignnersBest digital marketing e-book form bignners
Best digital marketing e-book form bignners
 
social media optimization complete indroduction
social media optimization complete indroductionsocial media optimization complete indroduction
social media optimization complete indroduction
 
A Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | BanyanbrainA Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | Banyanbrain
 
Fiverr's Product Marketing Interview Assignment
Fiverr's Product Marketing Interview AssignmentFiverr's Product Marketing Interview Assignment
Fiverr's Product Marketing Interview Assignment
 
Digital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G AgeDigital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G Age
 
5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software Solutions5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software Solutions
 
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
 
What’s the difference between Affiliate Marketing and Brand Partnerships?
What’s the difference between Affiliate Marketing and Brand Partnerships?What’s the difference between Affiliate Marketing and Brand Partnerships?
What’s the difference between Affiliate Marketing and Brand Partnerships?
 
The Evolution of Internet : How consumers use technology and its impact on th...
The Evolution of Internet : How consumers use technology and its impact on th...The Evolution of Internet : How consumers use technology and its impact on th...
The Evolution of Internet : How consumers use technology and its impact on th...
 
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdfResearch and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
 
Codes and Conventions of Film Magazine Websites.pptx
Codes and Conventions of Film Magazine Websites.pptxCodes and Conventions of Film Magazine Websites.pptx
Codes and Conventions of Film Magazine Websites.pptx
 
Miss Immigrant USA Activity Pageant Program.pdf
Miss Immigrant USA Activity Pageant Program.pdfMiss Immigrant USA Activity Pageant Program.pdf
Miss Immigrant USA Activity Pageant Program.pdf
 
Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...
Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...
Most Impressive Construction Leaders in Tech, Making Waves in the Industry, 2...
 
Professional Sales Representative by Sahil Srivastava.pptx
Professional Sales Representative by Sahil Srivastava.pptxProfessional Sales Representative by Sahil Srivastava.pptx
Professional Sales Representative by Sahil Srivastava.pptx
 
Fueling A_B experiments with behavioral insights (1).pdf
Fueling A_B experiments with behavioral insights (1).pdfFueling A_B experiments with behavioral insights (1).pdf
Fueling A_B experiments with behavioral insights (1).pdf
 
Prezentare Brandfluence 2023 - Social Media Trends
Prezentare Brandfluence 2023 - Social Media TrendsPrezentare Brandfluence 2023 - Social Media Trends
Prezentare Brandfluence 2023 - Social Media Trends
 
Codes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptxCodes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptx
 
14principles of management by hanry fayol.pptx
14principles of management by hanry fayol.pptx14principles of management by hanry fayol.pptx
14principles of management by hanry fayol.pptx
 
Most Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdf
Most Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdfMost Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdf
Most Influential HR Leaders Leading the Corporate World, 2024 (Final file).pdf
 

Doctors’ Views of Direct-to-Consumer Drug Advertising

  • 1. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  1 CMI/Compas Study on Doctors’ Views of Direct-to-Consumer Drug Advertising In Preparation for the FDA Survey of Clinicians on Direct-to-Consumer Drug Advertising Conducted on April 25, 2013
  • 2. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  2 In 2002, the FDA conducted a study of HCPs to understand their attitudes and behaviors associated with DTC advertising of prescription drugs… The 2002 physician questionnaire asked for information regarding the frequency of questions physicians received from patients, physicians’ responses to questions regarding patient questions, and prescribing behaviors involved in a recent, specific encounter in which a DTC- advertised drug was discussed. Finally, general questions were asked about physicians’ opinions regarding DTC advertising. The results of that study can be found on http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas /DrugMarketingAdvertisingandCommunicationsResearch/UCM152890. pdf This week the FDA announced their plan to conduct a new survey focusing on physicians and other healthcare professionals to understand the effect that direct-to-consumer (DTC) pharmaceutical advertising has on their prescribers’ behaviors; as well as gain their perspective on whether or not DTC drug marketing results in inappropriate requests for prescriptions or an overestimation by patients of their efficacy. As this announcement generated much curiosity with our media teams and our many clients, CMI/Compas decided to field our own ByDoctor® PulseTM study focusing on physicians perceptions of DTC – surveying both primary care and specialty physicians. Perhaps the responses here can serve as leading indicators for what’s to come… Survey Responders: 104 50% from Primary Care 50% from Specialty 48% agree that DTC informs, educates and empowers patients 68% agree that DTC encourages patients to contact a clinician 52% of agree that DTC removes stigma associated with certain diseases Only 20% of physicians agree that DTC advertising strengthens a patient’s relationship with a clinician. 81% of physicians agree DTC advertising encourages drug over-utilization 78% of physicians agree DTC advertising ultimately increases the cost of healthcare Over 89% have received a specific medication request from a patient as a result of an advertisement they saw. 43% changed their prescribing as a result. Summary of Key Findings
  • 3. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  3 On April 25, 2013, Compas conducted a ByDoctor® PULSE™ study of physicians to gauge HCP perceptions. HERE IS WHAT WE UNCOVERED…IN DETAIL!
  • 4. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  4 Nearly 53% of doctors believe Direct-to-Consumer pharmaceutical advertising should be scaled back 52.90% 18.30% 2.90% 26.00% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% Should be scaled back Should be eliminated Should be increased Should continue as is
  • 5. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  5 Over 89% have received a specific medication request from a patient as a result of an advertisement they saw. 43% changed their prescribing as a result. 10.60% 46.20% 43.30% Never received requests Received requests, but did not change prescribing Received requests and changed prescribing
  • 6. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  6 78% feel that Direct-to-Consumer advertising leads to a preference for brand name drugs when a generic is adequate 78.80% 21.20% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% 80.00% 90.00% 1 Yes No
  • 7. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  7 48% of physicians agree (5% strongly; 43% somewhat) that Direct-to-Consumer pharmaceutical advertising informs, educates and empowers patients. 4.80% 43.30% 7.70% 32.70% 11.50% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 8. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  8 68% of physicians agree (18% strongly; 50% somewhat) that Direct-to-Consumer pharmaceutical advertising encourages patients to contact a clinician 18.30% 50.00% 12.50% 14.40% 4.80% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 9. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  9 64% of physicians agree (13% strongly; 51% somewhat) that Direct-to-Consumer pharmaceutical advertising promotes patient dialogue with health care provider(s) 12.50% 51.00% 16.30% 14.40% 5.80% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 10. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  10 Only 20% of physicians agree (5% strongly; 15% somewhat) that Direct-to-Consumer pharmaceutical advertising strengthens a patient's relationship with a clinician 4.80% 15.40% 24.00% 39.40% 16.30% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% 45.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 11. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  11 52% of physicians agree (9% strongly; 43% somewhat) that Direct-to-Consumer pharmaceutical advertising removes stigma associated with certain diseases 8.60% 42.90% 21.90% 21.00% 5.70% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% 45.00% 50.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 12. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  12 53% of physicians disagree (19% strongly; 34% somewhat) Direct-to-Consumer pharmaceutical advertising reduces underdiagnoses and under-treatment of conditions 4.60% 22.20% 20.40% 34.30% 18.50% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 13. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  13 63% of physicians agree (15% strongly; 48% somewhat) that Direct-to-Consumer pharmaceutical advertising misinforms patients 15.00% 47.70% 17.80% 15.00% 4.70% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 14. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  14 74% of physicians agree (28% strongly; 46% somewhat) that Direct-to-Consumer pharmaceutical advertising overemphasizes drug benefits 27.60% 45.70% 17.10% 7.60% 1.90% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% 45.00% 50.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 15. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  15 50% of physicians disagree (18% strongly; 32% somewhat) that Direct-to-Consumer pharmaceutical advertising encourages patient compliance 6.70% 18.30% 25.00% 31.70% 18.30% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 16. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  16 52% of physicians disagree (21% strongly; 31% somewhat) Direct-to-Consumer pharmaceutical advertising encourages product competition and lower prices 5.70% 22.90% 20.00% 30.50% 21.00% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 17. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  17 68% of physicians agree (14% strongly; 54% somewhat) that Direct-to-Consumer pharmaceutical advertising promotes new drugs before safety profiles are fully known 13.90% 53.70% 11.10% 15.70% 5.60% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 18. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  18 81% of physicians agree (25% strongly; 56% somewhat) Direct- to-Consumer pharmaceutical advertising encourages drug overutilization 24.80% 56.20% 11.40% 5.70% 1.90% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 19. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  19 65% of physicians agree (20% strongly; 45% somewhat) that Direct-to-Consumer pharmaceutical advertising leads to inappropriate prescribing 20.00% 44.80% 21.90% 10.50% 2.90% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% 45.00% 50.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 20. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  20 51% of physicians agree (15% strongly; 36% somewhat) that Direct-to-Consumer pharmaceutical advertising wastes appointment time 15.00% 35.50% 22.40% 23.40% 3.70% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 21. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  21 65% of physicians agree (23% strongly; 42% somewhat) that Direct-to-Consumer pharmaceutical advertising is not rigorously regulated 23.10% 41.70% 16.70% 13.90% 4.60% 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 40.00% 45.00% Strongly Agree Somewhat Agree Don't Have an Opinion Somewhat Disagree Strongly Disagree
  • 22. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  22 78% of physicians agree that Direct-to-Consumer pharmaceutical advertising ultimately increases cost of healthcare 77.90% 5.80% 12.50% 3.80% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% 80.00% 90.00% Ultimately increases the cost of healthcare Ultimately reduces the cost of healthcare Does not change the cost of healthcare No opinion
  • 23. ByDoctor® PULSETM is a rapid response marketing research survey that provides instant audience insights around key campaign questions. • Research all healthcare professionals by specialty, geography, value segment and country. • Match your target list to over 1.7 million HCPs, spanning more than 27 specialties. • 100% customized surveys include up to 7 questions. • Receive responses within hours. Valuable, real-time insights and data with ByDoctor® PULSETM • Gauge brand awareness and track campaign effectiveness. • Anticipate prescribing patterns after change in product label, formulary access, price increase or indications. • Assess reaction to clinical trial data or promotional efforts by a competitor. • Evaluate satisfaction and message retention for educational programs or conferences. Highlights • Successfully engage with HCPs through their preferred media channels • Effectively measure target audience reactions as the market changes, including decisions made by governing bodies and current events affecting your brand • Launch key questions and receive responses rapidly, within hours • Integrate research findings with CMI/Compas’ experience and strategic customer insights across multi-channel, non-personal promotion campaigns
  • 24. © 2013 Communications Media, Inc. Confidential Material. All Rights Reserved.Page  24 To Find Out How Your Target Physicians Feel Towards DTC Advertising Please contact: oYour CMI Media Director or Compas Lead oOr Lindsay Dinan: ldinan@cmicompas.com